Strides

May 18, 2026

National Stock Exchange of India Limited
Exchange Plaza, Bandra-Kurla Complex,
Bandra (E), Mumbai - 400 051, Maharashtra.

BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai – 400 001, Maharashtra.

Symbol: STAR
Scrip Code: 532531
Dear Madam/ Sir,

Ref: Update with regard to our intimation dated May 18, 2026 regarding movement in Board of Directors, KMP and SMP of the Company

This has reference to our intimation of May 18, 2026, regarding movement in the Board of Directors, KMP and SMP of the Company.

We wish to inform that there is a typographical error in the designation of one of SMP of the Company.

Please find enclosed the revised disclosure for your information and records.

The above information will also be available on website of the Company at www.strides.com.

Thanks & Regards,
For Strides Pharma Science Limited,
Digitally signed by MANJULA RAMAMURTHY
Date: 2026.05.18 16:43:14
+05'30'

Manjula Ramamurthy
Company Secretary & Compliance Officer
ICSI Membership No.: A30515

Encl. as above

Strides Pharma Science Limited
CIN: L24230MH1990PLC057062
Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India | Tel: +91 80 6784 0000
Regd. Off: 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199
[email protected]; www.strides.com

Strides

May 18, 2026

National Stock Exchange of India Limited
Exchange Plaza, Bandra-Kurla Complex,
Bandra (E), Mumbai - 400 051, Maharashtra.

BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai – 400 001, Maharashtra.

Symbol: STAR
Scrip Code: 532531

Sub: Movement in Board of Directors, KMP and SMP of the Company

Ref: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

As part of strengthening executive management representation on the Board of Strides, and in line with the Company's comprehensive succession planning framework, including promotion of internal talent, Board of Directors of the Company, at their meeting held on May 18, 2026, based on the recommendations of Nomination and Remuneration Committee, have approved the following changes:

#	Name	Current Designation	New Role/ Designation
1	Venkata Seetharama Raju Pakalapati (Ramaraju PVS/ Ram) (DIN: 07500141)	Chief Operating Officer	Elevated as a Board Member & designated as Executive Director of the Company with effect from June 1, 2026
Consequently,
• Ram is identified as Key Managerial Personnel (KMP) with effect from June 1, 2026;
• And will cease as Senior Management Personnel (SMP) with effect from end of business hours of May 31, 2026.
2	Aditya Arun Kumar (DIN: 06999081)	Executive Director – Business Development	Redesignated as Non-Executive Director (Non-Independent) of the Company with effect from June 1, 2026.
Consequently, Aditya will cease to hold office of the Executive Director and KMP with effect from end of business hours of May 31, 2026.
3	Nandini Matiyani	Executive VP - HR	Nominated as SMP with effect from June 1, 2026.
4	Ariff Khan	Executive VP - Manufacturing Operations	Nominated as SMP with effect from June 1, 2026.

Strides

Consequent to the above, updated list of Board of Directors, KMP and SMP of the Company effective June 1, 2026 are as under:

1) Strides Board of Directors

#	Name of the Director	DIN	Designation
1	Arun Kumar	00084845	Founder & Non-Executive Director;
And Chairperson of the Board
2	Dr. Kausalya Santhanam	06999168	Independent Director
3	Mukta Arora	07225715	Independent Director
4	Homi Rustam Khusrokhan	00005085	Independent Director
5	Ameet Hariani	00087866	Independent Director
6	Subir Chakraborty	00130864	Independent Director
7	Aditya Arun Kumar	06999081	Non-Executive Director
8	Badree Komandur	07803242	Managing Director & Group CEO
9	Venkata Seetharama Raju Pakalapati (Ramaraju PVS)	07500141	Executive Director

2) Strides KMP

Updated list of KMP and those who are authorised to determine materiality of an event or information and making disclosure to the Stock Exchanges as per Regulation 30 of the SEBI Listing Regulations are as under:

#	Name of the KMP	Designation	Contact Details
1	Badree Komandur	Managing Director & Group CEO	Tel: +91 80 6784 0347
Email: [email protected]
2	Venkata Seetharama Raju Pakalapati (Ramaraju PVS)	Executive Director	Tel: +91 80 6784 0347
Email: [email protected]
3	Vikesh Kumar	Group CFO	Tel: +91 80 6784 0347
Email: [email protected]
4	Manjula Ramamurthy	Company Secretary & Compliance Officer	Tel: +91 80 6784 0734
Email: [email protected]

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062

Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India | Tel: +91 80 6784 0000

Regd. Off: 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai - 400 703, India | Tel: +91 22 2789 2924/3199

[email protected]; www.strides.com

Strides

A copy of ‘Policy for Determination of Materiality of Events and Information’ reflecting the updated list of KMPs will be made available on website of the Company at www.strides.com.

3) Strides SMP

#	Name of the SMP	Designation
1	Umesh Kale	Chief Quality Officer
2	Dr. Chithambaram Muthulingam	Executive VP – Research & Development
3	Sormistha Ghosh	Group GC, CRO & CSO
4	Nandini Matiyani	Executive VP – HR
5	Sugeet Chopra	Executive VP - Supply Chain Management
6	Ariff Khan	Executive VP – Manufacturing Operations
7	Amit Gupta	Senior VP - Taxation
8	Vikesh Kumar	Group CFO
9	Manjula Ramamurthy	Company Secretary & Compliance Officer

Disclosure required pursuant to Regulation 30 of the SEBI Listing Regulations read with applicable SEBI Circulars, is enclosed as an Annexure.

Board Meeting commenced at 12:30 hrs IST and concluded at 14:15 hrs IST.

The above information shall be made available on the website of the Company at www.strides.com.

This is for your information and records.

Thanks & Regards,

For Strides Pharma Science Limited,

MANJULA
RAMAMURTHY
Digitally signed by MANJULA RAMAMURTHY
Date: 2026.05.18 16:42:19
+05'30'

Manjula Ramamurthy
Company Secretary & Compliance Officer
ICSI Membership No.: A30515

Encl. as above

Strides Pharma Science Limited
CIN: L24230MH1990PLC057062
Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India | Tel: +91 80 6784 0000
Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199
[email protected]; www.strides.com

Strides

Annexure

Disclosure pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/ 49/ 14/ 14(7)2025-CFD-POD2/ I/ 3762/ 2026 dated January 30, 2026 for Board and Management Changes.

1) Appointment of Mr. Venkata Seetharama Raju Pakalapati (Ramaraju PVS/ Ram)
(DIN: 07500141) as Executive Director with effect from June 1, 2026

#	Particulars
1)	Reasons for change, viz., appointment, resignation, removal, death or otherwise; & Date of appointment/ re-appointment/ cessation and term of appointment/ re-appointment
	Appointment of Mr. Ramaraju PVS as whole-time director designated as Executive Director of the Company for a period of three years with effect from June 1, 2026, liable to retire by rotation, subject to Shareholders’ approval, Ramaraju is currently the Chief Operating Officer of the Company. Consequent to the said elevation as Executive Director, Ramaraju is: • Appointed as KMP of the Company effective June 1, 2026; • And will cease as SMP with effect from end of business hours of May 31, 2026.
2)	Brief Profile
	Ram has been part of Strides group for over 18 years and has held various leadership roles within the organization. His leadership approach is characterized by strategic foresight, collaborative synergy, and an unwavering commitment to excellence. A dynamic and results-oriented executive, Ram has a proven history of spearheading operational strategies that drive business expansion and efficiency. With more than two decades of experience in the pharmaceutical and healthcare industry, he excels in developing and implementing innovative solutions that streamline operations, enhance productivity, and yield outstanding outcomes. As Executive Director, Ram will be responsible for overseeing the global technical operations and strategic management of critical functions including Manufacturing, Supply Chain, Procurement and new digital initiatives.
3)	Disclosure of relationships between directors (in case of appointment of a director)
	None
4)	Other information pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/ 2018-19 and NSE Circular with ref. no. NSE/ CML/ 2018/ 24.
	Ram is not debarred from holding the office of Director pursuant to any SEBI Order or any other statutory authority.

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062

Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India | Tel: +91 80 6784 0000

Regd. Off: 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai - 400 703, India | Tel: +91 22 2789 2924/3199

[email protected]; www.strides.com

Strides

2) Change in designation of Mr. Aditya Arun Kumar (DIN: 06999081) from Executive Director – Business Development to Non-Executive Director of the Company with effect from June 1, 2026

#	Particulars
1)	Reasons for change, viz., appointment, resignation, removal, death or otherwise ;& Date of appointment/ re-appointment/ cessation and term of appointment/ re-appointment
	Mr. Aditya Arun Kumar (DIN: 06999081) is currently serving as Executive Director – Business Development of the Company.

Aditya played a significant role in expanding and strengthening the partnered and B2B business verticals, leveraging his experience of having led the B2B business since 2022.

His engagement in the executive role was intended to provide focused leadership and stability to these strategic growth initiatives. Over the past two years, he has contributed meaningfully to scaling the business and establishing robust governance frameworks to support sustainable growth.

Aditya has now decided to step down from his executive role, in line with promoters’ stated intention to further professionalize the management of Strides. He will continue to support the Company’s leadership in his capacity as a Non-Executive Director on the Board of the Company.

Accordingly, Aditya has been redesignated and appointed as Non-Executive Director (Non-Independent Director) of the Company with effect from June 1, 2026, liable to retire by rotation, subject to Shareholders’ approval.

Consequently, Aditya will cease to hold office of Executive Director - Business Development and KMP of the Company with effect from end of business hours of May 31, 2026. |
| 2) | Brief profile |
| | Aditya holds a Bachelor’s Degree in Biomedical Sciences from Newcastle University and a Master of Research in Biophysics from King’s College, London.

He commenced his career with Strides as a Management Trainee and has since held multiple roles across Strides and the promoter Family Office, gaining diverse experience across functions.

Aditya has over 13 years of experience in the pharmaceutical industry, with a strong focus on Business Development. Prior to leading the B2B business at Strides, he played a key role in the successful integration of two acquired consumer divisions.

Between 2017 and 2022, he led the operations of a promoter-funded pharmaceutical start-up, which developed a differentiated technology platform for oral lyophilisates.

Since June 2022, Aditya has been heading the Global Partnered Business at Strides. In this role, he has been instrumental in expanding the Company’s customer base across geographies, driving growth, and enhancing the scale and sustainability of the business. |

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062

Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India | Tel: +91 80 6784 0000

Regd. Off: 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199

[email protected]; www.strides.com

Strides

	As a Non-Executive Director, Aditya will continue to support the Company by providing oversight on growth initiatives and contributing to its long-term strategic direction.
3)	Disclosure of relationships between directors (in case of appointment of a director)
	Aditya is son of Mr. Arun Kumar, Founder and Non-Executive Chairperson of the Company and is part of the Promoter Group of the Company.

Except the above, Aditya is not related to any other Directors of the Company. |
| 4) | Other information pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/ 2018-19 and NSE Circular with ref. no. NSE/ CML/ 2018/ 24. |
| | Aditya is not debarred from holding the office of Director pursuant to any SEBI Order or any other statutory authority. |

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062

Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India | Tel: +91 80 6784 0000

Regd. Off: 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199

[email protected]; www.strides.com

Strides

3) Ms. Nandini Matiyani as Senior Management Personnel of the Company with effect from June 1, 2026

#	Particulars
1)	Reasons for change, viz., appointment, resignation, removal, death or otherwise
	Ms. Nandini Matiyani is part of Strides since December 2025 and is currently Executive VP – HR.
Nandini is nominated as one of the Senior Management Personnel of the Company with effect from June 1, 2026 in line with the provisions of SEBI Listing Regulations.
2)	Date of appointment/ re-appointment/ cessation and term of appointment/ re-appointment
	As SMP, Nandini’s appointment is effective June 1, 2026.
Term of appointment is aligned to her employment with the Company.
3)	Brief profile
	Nandini brings over two decades of experience in human resources, with a strong track record in driving people strategy, leadership development, cultural transformation and workforce capability building across global organizations.
Prior to joining Strides, she held senior HR leadership roles at RateGain, Wipro, and OnMobile Global, where she led global HR business partnering, talent management, leadership hiring, and cultural transformation initiatives across diverse markets.
At Strides, she leads the global people agenda, driving initiatives to strengthen organizational culture, enhance workforce capabilities, and support the Company’s growth across geographies.
Nandini holds a B.Tech in Electronics & Communication Engineering from NIT Surat and a Diploma in International Business from the Symbiosis Institute of Foreign Trade, Pune.
4)	Disclosure of relationships between directors (in case of appointment of a director)
	Not Applicable
5)	Other information pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/ 2018-19 and NSE Circular with ref. no. NSE/ CML/ 2018/ 24.
	Not Applicable

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062

Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India | Tel: +91 80 6784 0000

Regd. Off: 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199

[email protected]; www.strides.com

Strides

4) Mr. Ariff Khan, Executive VP, Manufacturing Operations as Senior Management Personnel of the Company with effect from June 1, 2026

#	Particulars
1)	Reasons for change, viz., appointment, resignation, removal, death or otherwise
	Mr. Ariff Khan, Executive VP - Manufacturing Operations was directly reporting to Mr. Ramaraju PVS, who is currently elevated as a Board member.
Consequent to the above, Ariff is nominated as one of the Senior Management Personnel of the Company with effect from June 1, 2026 in line with the provisions of SEBI Listing Regulations.
2)	Date of appointment/ re-appointment/ cessation and term of appointment/ re-appointment
	As SMP, Ariff’s appointment is effective June 1, 2026.
Term of appointment is aligned to her employment with the Company.
3)	Brief profile
	Ariff has been associated with Strides since May 2024 and currently heads manufacturing operations across India.
Ariff holds a Master’s degree in Pharmacy and brings over 26 years of rich and diversified experience in the pharmaceutical sector. Over the course of his career, he has held several strategic leadership positions spanning Manufacturing Operations, Planning, Engineering, Quality and Supply Chain with leading organizations such as Cipla, Wockhardt, Cdymax, Novartis and Recipharm.
Ariff has demonstrated strong leadership in building and scaling world-class manufacturing capabilities, driving large-scale operational efficiencies and optimizing end-to-end processes. He is also keenly focused on leveraging digital transformation to enhance manufacturing excellence.
4)	Disclosure of relationships between directors (in case of appointment of a director)
	Not Applicable
5)	Other information pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/ 2018-19 and NSE Circular with ref. no. NSE/ CML/ 2018/ 24.
	Not Applicable

*****

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062

Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India | Tel: +91 80 6784 0000

Regd. Off: 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai - 400 703, India | Tel: +91 22 2789 2924/3199

[email protected]; www.strides.com

May 13, 2026

The Board of Directors
Strides Pharma Science Limited
Cyber One, Unit No. 902,
Plot No. 4 & 6, Sector 30A,
Vashi, Navi Mumbai - 400 703,

Dear Members of the Board,

Sub: Resignation from the position of Executive Director – Business Development

I hereby tender my resignation from the position of Executive Director – Business Development of Strides Pharma Science Limited with effect from end of business hours of May 31, 2026, pursuant to my decision to transition from an executive role to a non-executive role.

My decision to step down from the executive role is driven by the promoters’ stated intention to further professionalize the management of Strides and continue to support the leadership through my non-executive role on the Board.

I remain fully committed to the long-term success of Strides and, subject to necessary approvals, look forward to continuing my association with the Company in a Non-Executive Director capacity, where I shall continue to support the Board in overseeing strategic growth initiatives and long-term direction.

I take this opportunity to thank the Board, management team, and employees for their support and collaboration during my tenure. I shall ensure a smooth and orderly transition of responsibilities.

Thanks & Regards,